• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种作为蛋白质稳定剂用于治疗戈谢病的硝酮衍生的C5a官能化异法戈明的实用合成方法。

A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease.

作者信息

Li Huang-Yi, Chen Wei-An, Lin Hung-Yi, Tsai Chi-Wei, Chiu Yu-Ting, Yun Wen-Yi, Lee Ni-Chung, Chien Yin-Hsiu, Hwu Wuh-Liang, Cheng Wei-Chieh

机构信息

Genomics Research Center, Academia Sinica, 128, Section 2, Academia Road, Taipei, 11529, Taiwan.

Department of Pediatrics and Medical Genetics, National Taiwan University Hospital, 8 Chung-Shan South Road, Taipei, 10041, Taiwan.

出版信息

Commun Chem. 2024 Apr 20;7(1):91. doi: 10.1038/s42004-024-01164-9.

DOI:10.1038/s42004-024-01164-9
PMID:38643239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11032326/
Abstract

Isofagomine (IFG) and its analogues possess promising glycosidase inhibitory activities. However, a flexible synthetic strategy toward both C5a-functionalized IFGs remains to be explored. Here we show a practical synthesis of C5a-S and R aminomethyl IFG-based derivatives via the diastereoselective addition of cyanide to cyclic nitrone 1. Nitrone 1 was conveniently prepared on a gram scale and in high yield from inexpensive (-)-diethyl D-tartrate via a straightforward method, with a stereoselective Michael addition of a nitroolefin and a Nef reaction as key steps. A 268-membered library (134 × 2) of the C5a-functionalized derivatives was submitted to enzyme- or cell-based bio-evaluations, which resulted in the identification of a promising β-glucocerebrosidase (GCase) stabilizer demonstrating a 2.7-fold enhancement at 25 nM in p.Asn370Ser GCase activity and a 13-fold increase at 1 μM in recombinant human GCase activity in Gaucher cell lines.

摘要

异麦角胺(IFG)及其类似物具有良好的糖苷酶抑制活性。然而,针对C5a功能化IFG的灵活合成策略仍有待探索。在此,我们展示了一种通过氰化物向环状硝酮1的非对映选择性加成来实际合成基于C5a-S和R氨甲基IFG的衍生物的方法。硝酮1可通过一种直接的方法从廉价的(-)-二乙基D-酒石酸方便地以克级规模高产率制备,其中硝基烯烃的立体选择性迈克尔加成和涅夫反应为关键步骤。一个由268个成员(134×2)组成的C5a功能化衍生物文库接受了基于酶或细胞的生物评估,结果鉴定出一种有前景的β-葡萄糖脑苷脂酶(GCase)稳定剂,在25 nM时,其在p.Asn370Ser GCase活性方面提高了2.7倍,在1 μM时,在高雪氏细胞系中重组人GCase活性提高了13倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/5db1cfa4c952/42004_2024_1164_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/c49c2c2a638b/42004_2024_1164_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/c0800569416e/42004_2024_1164_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/2ea4efdce5cf/42004_2024_1164_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/ef18b4fea8ca/42004_2024_1164_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/d8142f217c57/42004_2024_1164_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/5db1cfa4c952/42004_2024_1164_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/c49c2c2a638b/42004_2024_1164_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/c0800569416e/42004_2024_1164_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/2ea4efdce5cf/42004_2024_1164_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/ef18b4fea8ca/42004_2024_1164_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/d8142f217c57/42004_2024_1164_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e304/11032326/5db1cfa4c952/42004_2024_1164_Fig6_HTML.jpg

相似文献

1
A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease.一种作为蛋白质稳定剂用于治疗戈谢病的硝酮衍生的C5a官能化异法戈明的实用合成方法。
Commun Chem. 2024 Apr 20;7(1):91. doi: 10.1038/s42004-024-01164-9.
2
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase.药物伴侣依发麦明能提高 Gaucher 病 L444P 突变β-葡萄糖苷酶的活性。
FEBS J. 2010 Apr;277(7):1618-38. doi: 10.1111/j.1742-4658.2010.07588.x. Epub 2010 Feb 10.
3
Piperidine Azasugars Bearing Lipophilic Chains: Stereoselective Synthesis and Biological Activity as Inhibitors of Glucocerebrosidase (GCase).具有亲脂链的哌啶氮杂糖:立体选择性合成及作为葡萄糖脑苷脂酶(GCase)抑制剂的生物活性。
J Org Chem. 2021 Sep 17;86(18):12745-12761. doi: 10.1021/acs.joc.1c01308. Epub 2021 Sep 1.
4
Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease.Isofagomine 对戈谢病酸性 β-葡萄糖苷酶变异体和底物水平的体外和体内影响。
J Biol Chem. 2012 Feb 3;287(6):4275-87. doi: 10.1074/jbc.M111.280016. Epub 2011 Dec 13.
5
Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.补体驱动葡萄糖神经酰胺积累和戈谢病中的组织炎症。
Nature. 2017 Mar 2;543(7643):108-112. doi: 10.1038/nature21368. Epub 2017 Feb 22.
6
Docking and SAR studies of D- and L-isofagomine isomers as human β-glucocerebrosidase inhibitors.D-和 L-异野尻霉素异构体作为人β-葡糖苷脑苷脂酶抑制剂的对接和 SAR 研究。
Bioorg Med Chem. 2011 Jun 1;19(11):3558-68. doi: 10.1016/j.bmc.2011.04.011. Epub 2011 Apr 13.
7
Isofagomine induced stabilization of glucocerebrosidase.异麦角胺诱导葡萄糖脑苷脂酶的稳定。
Chembiochem. 2008 Nov 3;9(16):2643-9. doi: 10.1002/cbic.200800249.
8
Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.聚羟化双环异脲和胍类化合物是强效的葡萄糖脑苷脂酶抑制剂,能以纳摩尔浓度增强戈谢细胞中的酶活性。
J Am Chem Soc. 2011 Apr 13;133(14):5474-84. doi: 10.1021/ja111480z. Epub 2011 Mar 17.
9
Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.潜在的药物伴侣 NCGC00241607 与突变型β-葡糖脑苷脂酶的结合位点及其在帕金森病和戈谢病患者来源细胞培养物中的疗效。
Int J Mol Sci. 2023 May 22;24(10):9105. doi: 10.3390/ijms24109105.
10
Stereoselective Synthesis of C-2 Alkylated Trihydroxypiperidines: Novel Pharmacological Chaperones for Gaucher Disease.C-2 烷基化三羟基哌啶的立体选择性合成:用于戈谢病的新型药理伴侣分子
ACS Med Chem Lett. 2019 Feb 8;10(4):621-626. doi: 10.1021/acsmedchemlett.8b00602. eCollection 2019 Apr 11.

本文引用的文献

1
Harnessing natural-product-inspired combinatorial chemistry and computation-guided synthesis to develop -glycan modulators as anticancer agents.利用受天然产物启发的组合化学和计算引导合成来开发聚糖调节剂作为抗癌剂。
Chem Sci. 2022 Apr 19;13(21):6233-6243. doi: 10.1039/d1sc05894k. eCollection 2022 Jun 1.
2
Synthesis of Nitrone-derived Pyrrolidine Scaffolds and Their Combinatorial Libraries to Develop Selective α-l-Rhamnosidase Inhibitors.硝酮衍生的吡咯烷骨架的合成及其组合文库以开发选择性 α-l-鼠李糖苷酶抑制剂。
Chem Asian J. 2022 Jul 15;17(14):e202200172. doi: 10.1002/asia.202200172. Epub 2022 May 23.
3
Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and -5a-Substituted Derivatives of 4--Isofagomine.
人溶酶体半乳糖苷酶活性的伴侣机制研究:高度官能化的氨基环戊烷和 4--异野尻霉素的 -5a-取代衍生物。
Molecules. 2020 Sep 3;25(17):4025. doi: 10.3390/molecules25174025.
4
From Synthesis to Characterization of Site-Selective PEGylated Proteins.从位点选择性聚乙二醇化蛋白质的合成到表征
Front Pharmacol. 2019 Dec 18;10:1450. doi: 10.3389/fphar.2019.01450. eCollection 2019.
5
4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations.4-表异石蒜堿衍生物作为治疗与β-半乳糖苷酶突变相关的溶酶体疾病的药理学伴侣:改进的合成和生物学研究。
Bioorg Med Chem. 2018 Nov 1;26(20):5462-5469. doi: 10.1016/j.bmc.2018.09.023. Epub 2018 Sep 21.
6
Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones.调节溶酶体贮积症中的蛋白质折叠:药理伴侣背后的化学原理。
Chem Sci. 2018 Jan 10;9(7):1740-1752. doi: 10.1039/c7sc04712f. eCollection 2018 Feb 21.
7
Synthesis of (3S,4S,5S)-trihydroxylpiperidine derivatives as enzyme stabilizers to improve therapeutic enzyme activity in Fabry patient cell lines.(3S,4S,5S)-三羟基哌啶衍生物的合成作为酶稳定剂,以提高法布里病患者细胞系中治疗酶的活性。
Eur J Med Chem. 2018 Jan 20;144:626-634. doi: 10.1016/j.ejmech.2017.12.036. Epub 2017 Dec 12.
8
Screening methods for identifying pharmacological chaperones.用于鉴定药理学伴侣分子的筛选方法。
Mol Biosyst. 2017 Mar 28;13(4):638-647. doi: 10.1039/c6mb00866f.
9
(5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.(5aR)-5a-C-戊基-4-表异法戈明:一种强大的溶酶体β-半乳糖苷酶抑制剂,也是与GM1神经节苷脂贮积症和B型莫尔基奥氏病相关突变的显著伴侣分子。
Eur J Med Chem. 2017 Jan 27;126:160-170. doi: 10.1016/j.ejmech.2016.09.095. Epub 2016 Sep 29.
10
Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201C.4-表异法戈明的C-5a-取代衍生物的合成:显著的β-半乳糖苷酶抑制剂及GM1-神经节苷脂贮积症相关人类溶酶体β-半乳糖苷酶突变体R201C的活性促进剂
Carbohydr Res. 2016 Jun 24;429:71-80. doi: 10.1016/j.carres.2016.03.020. Epub 2016 Mar 31.